Experiment summary for ENCSR036EGV

Summary

Status
released
Assay
ChIP-seq (TF ChIP-seq)
Target
CTCF
Biosample summary
Homo sapiens foreskin keratinocyte male newborn (2-4 days) treated with 1.2 mM calcium for 2.5 days
Biosample Type
primary cell
Replication type
anisogenic
Description
CTCF ChIP-seq on primary keratinocytes in day 3 of differentiation
Treatments
1.2 mM calcium (CHEBI:86158) for 2.5 days
Nucleic acid type
DNA
RNA integrity number
9 [1-1]8.5 [2-1]
Controls

Attribution

Genomics of Gene Regulation Project
Lab
Michael Snyder, Stanford
Award
U01HG007919 (Michael Snyder, Stanford)
Project
GGR
Aliases
michael-snyder:ggr-skin-chipseq-CTCF-day3
Date submitted
December 9, 2016
Date released
October 10, 2017
Treatment Time Series
ENCSR368WHD 

Encyclopedia Integration

Anisogenic replicates

Anisogenic replicate
Technical replicate
Summary
Biosample
Antibody
Library
11male newborn (2-4 days) foreskin keratinocyte primary cell treated with 1.2 mM calcium for 2.5 daysENCBS079LRUENCAB830JLBENCLB485MAN
21male newborn (2-4 days) foreskin keratinocyte primary cell treated with 1.2 mM calcium for 2.5 daysENCBS299ONKENCAB830JLBENCLB677WIK